These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28222771)
1. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway. Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871 [TBL] [Abstract][Full Text] [Related]
3. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling. Zhao K; Song X; Huang Y; Yao J; Zhou M; Li Z; You Q; Guo Q; Lu N Eur J Pharmacol; 2014 Aug; 737():57-69. PubMed ID: 24858369 [TBL] [Abstract][Full Text] [Related]
4. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB. Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411 [TBL] [Abstract][Full Text] [Related]
5. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034 [TBL] [Abstract][Full Text] [Related]
6. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703 [TBL] [Abstract][Full Text] [Related]
7. LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway. Sun L; Zhao Y; Shi H; Ma C; Wei L Oncol Rep; 2015 Dec; 34(6):3264-71. PubMed ID: 26397141 [TBL] [Abstract][Full Text] [Related]
8. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1. Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478 [TBL] [Abstract][Full Text] [Related]
9. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax. Zhang M; Liu LP; Chen Y; Tian XY; Qin J; Wang D; Li Z; Mo SL Life Sci; 2013 Jan; 92(1):55-62. PubMed ID: 23142241 [TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3. Abd El-Hafeez AA; Khalifa HO; Mahdy EAM; Sharma V; Hosoi T; Ghosh P; Ozawa K; Montano MM; Fujimura T; Ibrahim ARN; Abdelhamid MAA; Pack SP; Shouman SA; Kawamoto S Pharmacol Rep; 2019 Apr; 71(2):289-298. PubMed ID: 30826569 [TBL] [Abstract][Full Text] [Related]
11. An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells. Dewan MZ; Tomita M; Katano H; Yamamoto N; Ahmed S; Yamamoto M; Sata T; Mori N; Yamamoto N Int J Cancer; 2009 Feb; 124(3):622-9. PubMed ID: 18973272 [TBL] [Abstract][Full Text] [Related]
13. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63. Chow SE; Chang YL; Chuang SF; Wang JS Cancer Chemother Pharmacol; 2011 Oct; 68(4):835-45. PubMed ID: 21207227 [TBL] [Abstract][Full Text] [Related]
14. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling. Liu X; Tian S; Liu M; Jian L; Zhao L Int J Mol Med; 2016 Oct; 38(4):1250-6. PubMed ID: 27499272 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death. Shan X; Tian LL; Zhang YM; Wang XQ; Yan Q; Liu JW Int J Oncol; 2015 Aug; 47(2):701-9. PubMed ID: 26094873 [TBL] [Abstract][Full Text] [Related]
16. NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. Thompson RC; Herscovitch M; Zhao I; Ford TJ; Gilmore TD J Biol Chem; 2011 Jan; 286(3):1675-82. PubMed ID: 20947507 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817 [TBL] [Abstract][Full Text] [Related]
18. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Rahadiani N; Takakuwa T; Tresnasari K; Morii E; Aozasa K Biochem Biophys Res Commun; 2008 Dec; 377(2):579-583. PubMed ID: 18926796 [TBL] [Abstract][Full Text] [Related]
19. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. Kim HR; Park CG; Jung JY Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354 [TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of the canonical NF-κB signaling pathway in EBV-associated gastric carcinoma. Zhang Y; Liu W; Zhang W; Wang W; Song Y; Xiao H; Luo B Virology; 2019 Jun; 532():1-10. PubMed ID: 30974373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]